Viewing Study NCT07357051


Ignite Creation Date: 2026-03-26 @ 3:18 PM
Ignite Modification Date: 2026-03-31 @ 2:30 AM
Study NCT ID: NCT07357051
Status: RECRUITING
Last Update Posted: 2026-01-21
First Post: 2026-01-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase III Clinical Study Evaluating the Safety, Pharmacokinetics, and Efficacy of JKN2301 Dry Suspension in Pediatric Patients Aged 2 to Under 12 Years With Influenza
Sponsor: Joincare Pharmaceutical Group Industry Co., Ltd
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module